<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR47">
 <label>47</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Madelain</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Nguyen</surname>
    <given-names>TH</given-names>
   </name>
   <name>
    <surname>Olivo</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>de Lamballerie</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Guedj</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Taburet</surname>
    <given-names>AM</given-names>
   </name>
   <name>
    <surname>Mentre</surname>
    <given-names>F</given-names>
   </name>
  </person-group>
  <article-title>Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials</article-title>
  <source>Clin Pharmacokinet</source>
  <year>2016</year>
  <volume>55</volume>
  <issue>8</issue>
  <fpage>907</fpage>
  <lpage>23</lpage>
  <pub-id pub-id-type="doi">10.1007/s40262-015-0364-1</pub-id>
  <?supplied-pmid 26798032?>
  <pub-id pub-id-type="pmid">26798032</pub-id>
 </element-citation>
</ref>
